알림

Propanc Biopharma Inc. (PPCB)

NasdaqCM: PPCB · 실시간 가격 · USD

1.22

+0.01 (0.83%)

종가 기준: Aug 13, 2026, 3:59 PM

0.83% (1D)

매수호가	0.9
시가총액	2.78M
매출 (ttm)	n/a
순이익 (ttm)	-19.29M
베타	3.27
EPS (ttm)	575.21
P/E (ttm)	0
선행 P/E	n/a
P/B (ttm)	0.11
P/S (ttm)	n/a
Earnings Date	n/a

매도호가	1.56
거래량	33,379
평균 거래량 (20일)	3,937,100
시가	1.24
전일 종가	1.21
일중 범위	1.20 - 1.26
52주 범위	0.95 - 260.00
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

PPCB 소개

Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreemen...

[더 보기]

산업 Biotechnology

섹터 Healthcare

IPO 일자 Jan 7, 2013

직원 수 1

상장 거래소 NasdaqCM

티커 PPCB

웹사이트 https://www.propanc.com

전체 기업 정보